1,559
Views
30
CrossRef citations to date
0
Altmetric
Review

Relationship between nasopharyngeal microbiota and patient’s susceptibility to viral infection

, &
Pages 437-447 | Received 11 Feb 2019, Accepted 16 May 2019, Published online: 29 May 2019

References

  • Paul Glezen W, Schmier JK, Kuehn CM, et al. The burden of influenza B: a structured literature review. Am J Public Health. 2013;103:e43–51.
  • Fendrick AM, Monto  AS, Nightengale B, et al. The economic burden of non–influenza-related viral respiratory tract infection in the United States. Arch Intern Med. 2003;163:487–494.
  • Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360:588–598.
  • Byington CL, Ampofo K, Stockmann C, et al. Community surveillance of respiratory viruses among families in the utah better identification of germs-longitudinal viral epidemiology (BIG-LoVE) study. Clin Infect Dis. 2015;61:1217–1224.
  • Tokars JI, Olsen SJ, Reed C. Seasonal Incidence of Symptomatic Influenza in the United States. Clin Infect Dis. 2018;66:1511–1518.
  • Morris DE, Cleary DW, Clarke SC. Secondary bacterial infections associated with influenza pandemics. Front Microbiol. 2017;8:1041.
  • Up to 650 000 people die of respiratory diseases linked to seasonal flu each year [Internet]. [ cited 2019 Jan 16]. Available from: https://www.who.int/news-room/detail/14-12-2017-up-to-650-000-people-die-of-respiratory-diseases-linked-to-seasonal-flu-each-year.
  • Byrd AL, Segre JA. Infectious disease. Adapting Koch’s postulates. Science. 2016;351:224–226.
  • Tauber AI. Metchnikoff and the phagocytosis theory. Nat Rev Mol Cell Biol. 2003;4:897.
  • Gordon S. Elie Metchnikoff: father of natural immunity. Eur J Immunol. 2008;38:3257–3264.
  • Vasiljevic T, Shah NP. Probiotics – from Metchnikoff to bioactives. Int Dairy J. 2008;18:714–728.
  • Lagier J-C, Dubourg G, Amrane S, et al. Koch postulate: why should we grow bacteria? Arch Med Res. 2017;48:774–779.
  • O’Dwyer DN, Dickson RP, Moore BB. The lung microbiome, immunity, and the pathogenesis of chronic lung disease. J Immunol. 2016;196:4839–4847.
  • Dickson RP, Erb-Downward JR, Prescott HC, et al. Cell-associated bacteria in the human lung microbiome. Microbiome. 2014;2:28.
  • Teo SM, Mok D, Pham K, et al. The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development. Cell Host Microbe. 2015;17:704–715.
  • Langevin S, Pichon M, Smith E, et al. Early nasopharyngeal microbial signature associated with severe influenza in children: a retrospective pilot study. J Gen Virol. 2017;98:2425–2437.
  • Edouard S, Million M, Bachar D, et al. The nasopharyngeal microbiota in patients with viral respiratory tract infections is enriched in bacterial pathogens. Eur J Clin Microbiol Infect Dis. 2018;37:1725–1733.
  • Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis. 2008;198:962–970.
  • Louis J, Jean C, Chen TH, et al. Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. MMWR Morb Mortal Wkly Rep. 2009;58:1071–1074.
  • Rice TW, Rubinson L, Uyeki TM, et al. Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit Care Med. 2012;40:1487–1498.
  • Kupperberg P. The influenza pandemic of 1918–1919. New York, USA: Infobase Publishing; 2009.
  • Wollstein M. Pfeiffer’s bacillus and influenza : a serological study. J Exp Med. 1919;30:555–568.
  • Shope RE. The etiology of swine influenza. Science. 1931;73:214–215.
  • Wolter N, Tempia S, Cohen C, et al. High nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive pneumococcal pneumonia. J Infect Dis. 2014;210:1649–1657.
  • Klugman KP, Madhi SA, Ginsburg AS, et al. The role of bacterial vaccines in the prevention of influenza mortality. Lancet Glob Health. 2018;6:e1268–e1269.
  • Madhi SA, Ludewick H, Kuwanda L, et al. Pneumococcal coinfection with human metapneumovirus. J Infect Dis. 2006;193:1236–1243.
  • Papenburg J, Baz M, Hamelin M-E, et al. Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratory-confirmed secondary attack rates and evidence of asymptomatic infections. Clin Infect Dis. 2010;51:1033–1041.
  • Jartti T, Jartti L, Peltola V, et al. Identification of respiratory viruses in asymptomatic subjects: asymptomatic respiratory viral infections. Pediatr Infect Dis J. 2008;27:1103–1107.
  • Bogaert D, De Groot R, Hermans PWM. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis. 2004;4:144–154.
  • Collado MC, Rautava S, Aakko J, et al. Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. Sci Rep. 2016;6:23129.
  • Bosch AA, Levin E, van Houten MA, et al. Development of upper respiratory tract microbiota in infancy is affected by mode of delivery. EBioMedicine. 2016;9:336–345.
  • Biesbroek G, Bosch AATM, Wang X, et al. The impact of breastfeeding on nasopharyngeal microbial communities in infants. Am J Respir Crit Care Med. 2014;190:298–308.
  • Togo A, Dufour J-C, Lagier J-C, et al. Repertoire of human breast and milk microbiota. Fut Microbiol. 2018. (in press). DOI:10.2217/fmb-2018-0317.
  • Biesbroek G, Tsivtsivadze E, Sanders EAM, et al. Early respiratory microbiota composition determines bacterial succession patterns and respiratory health in children. Am J Respir Crit Care Med. 2014;190:1283–1292.
  • Ashhurst-Smith C, Hall ST, Stuart J, et al. Alloiococcus otitidis: an emerging pathogen in otitis media. J Infect. 2012;64:233–235.
  • Wang H, Dai W, Feng X, et al. Microbiota composition in upper respiratory tracts of healthy children in Shenzhen, China, differed with respiratory sites and ages. Biomed Res Int. 2018;2018:6515670.
  • Ling Z, Liu X, Luo Y, et al. Pyrosequencing analysis of the human microbiota of healthy Chinese undergraduates. BMC Genomics. 2013;14:390.
  • Stearns JC, Davidson CJ, McKeon S, et al. Culture and molecular-based profiles show shifts in bacterial communities of the upper respiratory tract that occur with age. Isme J. 2015;9:1268.
  • Numminen E, Chewapreecha C, Turner C, et al. Climate induces seasonality in pneumococcal transmission. Sci Rep. 2015;5:11344.
  • Hang J, Zavaljevski N, Yang Y, et al. Composition and variation of respiratory microbiota in healthy military personnel. PLoS One. 2017;12:e0188461.
  • De Boeck I, Wittouck S, Wuyts S, et al. Comparing the healthy nose and nasopharynx microbiota reveals continuity as well as niche-specificity. Front Microbiol. 2017;8:2372.
  • Abdullahi O, Nyiro J, Lewa P, et al. The descriptive epidemiology of Streptococcus pneumoniae and Haemophilus influenzae nasopharyngeal carriage in children and adults in Kilifi district, Kenya. Pediatr Infect Dis J. 2008;27:59–64.
  • Bojang A, Jafali J, Egere UE, et al. Seasonality of pneumococcal nasopharyngeal carriage in rural gambia determined within the context of a cluster randomized pneumococcal vaccine trial. PLoS One. 2015;10:e0129649.
  • Chonmaitree T, Jennings K, Golovko G, et al. Nasopharyngeal microbiota in infants and changes during viral upper respiratory tract infection and acute otitis media. PLoS One. 2017;12:e0180630.
  • Florin TA, Plint AC, Zorc JJ. Viral bronchiolitis. Lancet. 2017;389:211–224.
  • Vissing NH, Chawes BL, Bisgaard H. Increased risk of pneumonia and bronchiolitis after bacterial colonization of the airways as neonates. Am J Respir Crit Care Med. 2013;188:1246–1252.
  • Teo SM, Tang HHF, Mok D, et al. Airway microbiota dynamics uncover a critical window for interplay of pathogenic bacteria and allergy in childhood respiratory disease. Cell Host Microbe. 2018;24:341–352.e5.
  • Korten I, Mika M, Klenja S, et al. Interactions of respiratory viruses and the nasal microbiota during the first year of life in healthy infants. mSphere. 2016;1:e00312–16.
  • Hasegawa K, Linnemann RW, Mansbach JM, et al. Nasal airway microbiota profile and severe bronchiolitis in infants: a case-control study. Pediatr Infect Dis J. 2017;36:1044–1051.
  • Rosas-Salazar C, Shilts MH, Tovchigrechko A, et al. Differences in the nasopharyngeal microbiome during acute respiratory tract infection with human rhinovirus and respiratory syncytial virus in infancy. J Infect Dis. 2016;214:1924–1928.
  • Hyde ER, Petrosino JF, Piedra PA, et al. Nasopharyngeal Proteobacteria are associated with viral etiology and acute wheezing in children with severe bronchiolitis. J Allergy Clin Immunol. 2014;133:1220–1222.
  • Bosch AATM, Biesbroek G, Trzcinski K, et al. Viral and bacterial interactions in the upper respiratory tract. PLoS Pathog. 2013;9:e1003057.
  • Sakwinska O, Schmid VB, Berger B, et al. Nasopharyngeal microbiota in healthy children and pneumonia patients. J Clin Microbiol. 2014;52(5):1590-1594.
  • Yi H, Yong D, Lee K, et al. Profiling bacterial community in upper respiratory tracts. BMC Infect Dis. 2014;14:583.
  • Rosas-Salazar C, Shilts MH, Tovchigrechko A, et al. Nasopharyngeal microbiome in respiratory syncytial virus resembles profile associated with increased childhood asthma risk. Am J Respir Crit Care Med. 2016;193:1180–1183.
  • Waa DSP, Heinonen S, Hasrat R, et al. Nasopharyngeal microbiota, host transcriptome, and disease severity in children with respiratory syncytial virus infection. Am J Respir Crit Care Med. 2016;194:1104–1115.
  • Mansbach JM, Hasegawa K, Piedra PA, et al. Haemophilus-dominant nasopharyngeal microbiota is associated with delayed clearance of respiratory syncytial virus in infants hospitalized for bronchiolitis. J Infect Dis. 2018;219(11):1804–1808.
  • Ederveen THA, Ferwerda G, Ahout IM, et al. Haemophilus is overrepresented in the nasopharynx of infants hospitalized with RSV infection and associated with increased viral load and enhanced mucosal CXCL8 responses. Microbiome. 2018;6:10.
  • Wen Z, Xie G, Zhou Q, et al. Distinct nasopharyngeal and oropharyngeal microbiota of children with influenza a virus compared with healthy children. Biomed Res Int. 2018;2018:6362716.
  • Hasegawa K, Mansbach JM, Ajami NJ, et al. Association of nasopharyngeal microbiota profiles with bronchiolitis severity in infants hospitalised for bronchiolitis. Eur Respir J. 2016;48:1329–1339.
  • Santee CA, Nagalingam NA, Faruqi AA, et al. Nasopharyngeal microbiota composition of children is related to the frequency of upper respiratory infection and acute sinusitis. Microbiome. 2016;4:34.
  • Lee KH, Gordon A, Shedden K, et al. The respiratory microbiome and susceptibility to influenza virus infection. PloS One. 2019;14:e0207898.
  • Borges LGDA, Giongo A, Pereira LDM, et al. Comparison of the nasopharynx microbiome between influenza and non-influenza cases of severe acute respiratory infections: a pilot study. Health Sci Rep. 2018;1:e47.
  • Allen EK, Koeppel AF, Hendley JO, et al. Characterization of the nasopharyngeal microbiota in health and during rhinovirus challenge. Microbiome. 2014;2:22.
  • Lehtinen MJ, Hibberd AA, Mannikko S, et al. Nasal microbiota clusters associate with inflammatory response, viral load, and symptom severity in experimental rhinovirus challenge. Sci Rep. 2018;8:11411.
  • Heinonen S, Jartti T, Garcia C, et al. Rhinovirus detection in symptomatic and asymptomatic children: value of host transcriptome analysis. Am J Respir Crit Care Med. 2016;193:772–782.
  • Sundell N, Andersson L-M, Brittain-Long R, et al. PCR detection of respiratory pathogens in asymptomatic and symptomatic adults. J Clin Microbiol. 2019;57(1).
  • Toivonen L, Jr CA C, Gern JE, et al. Association between rhinovirus species and nasopharyngeal microbiota in infants with severe bronchiolitis. J Allergy Clin Immunol. 2019;143(5):1925–1928.
  • Brown RL, Sequeira RP, Clarke TB. The microbiota protects against respiratory infection via GM-CSF signaling. Nat Commun. 2017;8:1512.
  • Scheiblauer H, Reinacher M, Tashiro M, et al. Interactions between bacteria and influenza A virus in the development of influenza pneumonia. J Infect Dis. 1992;166:783–791.
  • Tashiro M, Ciborowski P, Klenk H-D, et al. Role of Staphylococcus protease in the development of influenza pneumonia. Nature. 1987;325:536.
  • Sajjan US, Jia Y, Dc N, et al. H. influenzae potentiates airway epithelial cell responses to rhinovirus by increasing ICAM-1 and TLR3 expression. Faseb J. 2006;20:2121–2123.
  • Gulraiz F, Bellinghausen C, Bruggeman CA, et al. Haemophilus influenzae increases the susceptibility and inflammatory response of airway epithelial cells to viral infections. Faseb J. 2015;29:849–858.
  • Bellinghausen C, Gulraiz F, Heinzmann ACA, et al. Exposure to common respiratory bacteria alters the airway epithelial response to subsequent viral infection. Respir Res. 2016;17:68.
  • Heinrich A, Haarmann H, Zahradnik S, et al. Moraxella catarrhalis decreases antiviral innate immune responses by down-regulation of TLR3 via inhibition of p53 in human bronchial epithelial cells. Faseb J. 2016;30:2426–2434.
  • Wang X, Quinn PJ. Endotoxins: lipopolysaccharides of gram-negative bacteria. Endotoxins: structure, function and recognition. Dordrecht, Netherlands: Springer; 2010. p. 3–25.
  • Short KR, Vissers M, de Kleijn S, et al. Bacterial lipopolysaccharide inhibits influenza virus infection of human macrophages and the consequent induction of CD8+ T cell immunity. J Innate Immun. 2014;6:129–139.
  • Schweda EKH, Richards JC. Profiling LPS glycoforms of non-typeable Haemophilus influenzae by multiple-stage tandem mass spectrometry. Methods Mol Biol. 2010;600:79–92.
  • Peng D, Hong W, Choudhury BP, et al. Moraxella catarrhalis bacterium without endotoxin, a potential vaccine candidate. Infect Immun. 2005;73:7569–7577.
  • Ashhurst-Smith C, Hall ST, Burns CJ, et al. Induction of inflammatory responses from THP-1 cells by cell-free filtrates from clinical isolates of Alloiococcus otitidis. Innate Immun. 2014;20:283–289.
  • Biesbroek G, Wang X, Keijser BJ, et al. Seven-valent pneumococcal conjugate vaccine and nasopharyngeal microbiota in healthy children. Emerg Infect Dis. 2014;20:201.
  • Spijkerman J, Prevaes SMPJ, Ejm VG, et al. Long-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis. PLoS One. 2012;7:e39730.
  • Camilli R, Vescio MF, Giufre M, et al. Carriage of haemophilus influenzae is associated with pneumococcal vaccination in Italian children. Vaccine. 2015;33:4559–4564.
  • van Den Broek MFL, De Boeck I, Claes IJJ, et al. Multifactorial inhibition of lactobacilli against the respiratory tract pathogen Moraxella catarrhalis. Benef Microbes. 2018;9:429–439.
  • Bidossi A, De Grandi R, Toscano M, et al. Probiotics Streptococcus salivarius 24SMB and Streptococcus oralis 89a interfere with biofilm formation of pathogens of the upper respiratory tract. BMC Infect Dis. 2018;18:653.
  • Norton EB, Clements JD, Voss TG, et al. Prophylactic administration of bacterially derived immunomodulators improves the outcome of influenza virus infection in a murine model. J Virol. 2010;84:2983–2995.
  • Chiba E, Tomosada Y, Vizoso-Pinto MG, et al. Immunobiotic Lactobacillus rhamnosus improves resistance of infant mice against respiratory syncytial virus infection. Int Immunopharmacol. 2013;17:373–382.
  • Roos K, Hakansson EG, Holm S. Effect of recolonisation with “interfering” alpha streptococci on recurrences of acute and secretory otitis media in children: randomised placebo controlled trial. Bmj. 2001;322:210–212.
  • Skovbjerg S, Roos K, Holm SE, et al. Spray bacteriotherapy decreases middle ear fluid in children with secretory otitis media. Arch Dis Child. 2009;94:92–98.
  • Teng F, Nair SSD, Zhu P, et al. Impact of DNA extraction method and targeted 16S-rRNA hypervariable region on oral microbiota profiling. Sci Rep. 2018;8:16321.
  • Jeon Y-S, Park S-C, Lim J, et al. Improved pipeline for reducing erroneous identification by 16S rRNA sequences using the Illumina MiSeq platform. J Microbiol. 2015;53:60–69.
  • Rossi-Tamisier M, Benamar S, Raoult D, et al. Cautionary tale of using 16S rRNA gene sequence similarity values in identification of human-associated bacterial species. Int J Syst Evol Microbiol. 2015;65:1929–1934.
  • Verduin CM, Hol C, Fleer A, et al. Moraxella catarrhalis: from emerging to established pathogen. Clin Microbiol Rev. 2002;15:125–144.
  • Ichinohe T, Pang IK, Kumamoto Y, et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci U S A. 2011;108:5354–5359.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.